Perrigo Company plc Depreciation
Perrigo Company plc (PRGO) reported Depreciation of $41.40 million for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-05
- Perrigo Company plc depreciation for the quarter ending 2026-06-27 was $41.40M, a 41.30% increase year-over-year.
- Perrigo Company plc depreciation for the quarter ending 2026-03-28 was $28.90M, a 16.06% increase year-over-year.
- Perrigo Company plc depreciation for the quarter ending 2025-06-28 was $29.30M.
- Perrigo Company plc depreciation for the quarter ending 2025-03-29 was $24.90M.
- Perrigo Company plc depreciation for fiscal 2025 was $114.80M, a 17.86% increase from fiscal 2024.
- Perrigo Company plc depreciation for fiscal 2024 was $97.40M, a 3.95% increase from fiscal 2023.
- Perrigo Company plc depreciation for fiscal 2023 was $93.70M, a 8.70% increase from fiscal 2022.
- Perrigo Company plc depreciation for fiscal 2022 was $86.20M, a 0.69% decline from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|
| 2026-06-27 | $41.40M 10-Q · filed 2026-08-05 | $70.10M 10-Q · filed 2026-08-05 | ||
| 2026-03-28 | $28.90M 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | $114.80M 10-K · filed 2026-02-26 | |||
| 2025-06-28 | $29.30M 10-Q · filed 2026-08-05 | $54.80M 10-Q · filed 2026-08-05 | ||
| 2025-03-29 | $24.90M 10-Q · filed 2026-05-06 | |||
| 2024-12-31 | $97.40M 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $93.70M 10-K · filed 2026-02-26 | |||
| 2022-12-31 | $86.20M 10-K · filed 2025-02-28 | |||
| 2021-12-31 | $86.80M 10-K · filed 2024-02-27 | |||
| 2020-12-31 | $75.60M 10-K · filed 2023-02-28 | $90.10M 10-K · filed 2021-03-01 | ||
| 2019-12-31 | $77.50M 10-K · filed 2022-03-01 | $91.00M 10-K · filed 2020-02-27 | ||
| 2018-12-31 | $90.00M 10-K · filed 2021-03-01 | |||
| 2017-12-31 | $95.20M 10-K · filed 2020-02-27 | |||
| 2016-12-31 | $100.20M 10-K · filed 2019-02-27 | |||
| 2015-12-31 | $53.80M 10-K · filed 2018-03-01 | |||
| 2015-06-27 | $84.30M 10-K · filed 2018-03-01 | |||
| 2014-06-28 | $77.90M 10-K · filed 2017-05-22 | |||
| 2013-06-29 | $66.20M 10-KT · filed 2016-02-25 | |||
| 2012-06-30 | $58.20M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |